{
  "id": "tia",
  "title": "Transient Ischemic Attack (TIA)",
  "version": "1.0",
  "icd10": [
    "** G45.9 (Transient cerebral ischemic attack",
    "unspecified)"
  ],
  "scope": "** Urgent evaluation, risk stratification (ABCD2), and secondary stroke prevention. Excludes completed stroke (see Acute Ischemic Stroke protocol).",
  "notes": [],
  "sections": {
    "Laboratory Workup": {
      "Essential/Core Labs": [
        {
          "item": "CBC with differential",
          "rationale": "Polycythemia, thrombocytosis as stroke risk; anemia evaluation",
          "target": "Normal",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "BMP",
          "rationale": "Electrolytes; glucose for hypoglycemia mimic; creatinine for contrast",
          "target": "Normal",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Glucose (fingerstick)",
          "rationale": "Rule out hypoglycemia as TIA mimic",
          "target": "70-180 mg/dL",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "-"
        },
        {
          "item": "PT/INR, PTT",
          "rationale": "Baseline coagulation; evaluate if on anticoagulation",
          "target": "Normal or therapeutic",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Lipid panel (fasting)",
          "rationale": "LDL target <70 for secondary prevention",
          "target": "LDL <70 mg/dL",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "HbA1c",
          "rationale": "Diabetes assessment; target <7%",
          "target": "<7%",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "TSH",
          "rationale": "Hyperthyroidism associated with atrial fibrillation",
          "target": "Normal",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Troponin",
          "rationale": "Concurrent cardiac ischemia; AF with rapid rate",
          "target": "Negative",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "-"
        }
      ],
      "Extended Workup": [
        {
          "item": "Homocysteine",
          "rationale": "Elevated levels increase stroke risk",
          "target": "<15 μmol/L",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Lipoprotein(a)",
          "rationale": "Independent cardiovascular risk marker",
          "target": "<30 mg/dL",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "hsCRP",
          "rationale": "Inflammatory marker; guides statin intensity",
          "target": "<2 mg/L",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "BNP/NT-proBNP",
          "rationale": "Heart failure; cardiac strain; AF risk",
          "target": "Age-adjusted normal",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Uric acid",
          "rationale": "Elevated associated with increased stroke risk",
          "target": "<6 mg/dL",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Rare/Specialized": [
        {
          "item": "Hypercoagulability panel",
          "rationale": "Age <50, cryptogenic, recurrent events; includes Factor V Leiden, prothrombin mutation, protein C/S, antithrombin III",
          "target": "Negative",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-"
        },
        {
          "item": "Antiphospholipid antibodies",
          "rationale": "Lupus anticoagulant, anticardiolipin, anti-β2GP1; young stroke",
          "target": "Negative",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-"
        },
        {
          "item": "Hemoglobin electrophoresis",
          "rationale": "Sickle cell disease if not known",
          "target": "No sickling",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-"
        },
        {
          "item": "ESR, ANA",
          "rationale": "Suspected vasculitis",
          "target": "Normal/Negative",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-"
        },
        {
          "item": "Fabry disease testing (α-galactosidase A)",
          "rationale": "Young cryptogenic stroke, family history, angiokeratomas",
          "target": "Normal enzyme activity",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-"
        }
      ]
    },
    "Imaging & Studies": {
      "Essential/First-line": [
        {
          "item": "CT Head non-contrast",
          "timing": "Immediate",
          "target": "No hemorrhage; rule out stroke mimic",
          "contraindications": "None",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "-"
        },
        {
          "item": "MRI Brain with DWI",
          "timing": "Within 24 hours",
          "target": "No restricted diffusion (DWI+/ADC-) confirming infarct vs true TIA",
          "contraindications": "MRI-incompatible devices",
          "ED": "URGENT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "-"
        },
        {
          "item": "CTA Head and Neck",
          "timing": "Same visit",
          "target": "No significant stenosis (>50%) in carotid, vertebral, or intracranial vessels",
          "contraindications": "Contrast allergy, CKD (relative)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "-"
        },
        {
          "item": "MRA Head and Neck",
          "timing": "Alternative to CTA",
          "target": "Patent vessels; no stenosis >50%",
          "contraindications": "MRI contraindications",
          "ED": "URGENT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Carotid duplex ultrasound",
          "timing": "Within 24-48 hours",
          "target": "<50% stenosis bilaterally",
          "contraindications": "None",
          "ED": "URGENT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "ECG (12-lead)",
          "timing": "Immediate",
          "target": "Sinus rhythm; no AF, LVH, or acute changes",
          "contraindications": "None",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Transthoracic echocardiogram",
          "timing": "Within 24-48 hours",
          "target": "No thrombus, PFO, or significant valvular disease",
          "contraindications": "None",
          "ED": "URGENT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Extended": [
        {
          "item": "Cardiac telemetry (continuous)",
          "timing": "24-72 hours minimum",
          "target": "No atrial fibrillation or flutter",
          "contraindications": "None",
          "ED": "URGENT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "-"
        },
        {
          "item": "Holter monitor (24-48 hour)",
          "timing": "Outpatient",
          "target": "No paroxysmal AF",
          "contraindications": "None",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Extended cardiac monitoring (14-30 day)",
          "timing": "Cryptogenic stroke/TIA",
          "target": "Detect paroxysmal AF",
          "contraindications": "None",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Transesophageal echocardiogram",
          "timing": "Cryptogenic, young, embolic",
          "target": "No PFO, LAA thrombus, aortic arch atheroma",
          "contraindications": "Esophageal pathology",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "EXT",
          "ICU": "-"
        },
        {
          "item": "Bubble study (TTE or TEE)",
          "timing": "Suspected paradoxical embolism",
          "target": "No right-to-left shunt",
          "contraindications": "None specific",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Rare/Specialized": [
        {
          "item": "CT/MR perfusion",
          "timing": "Uncertain timing, large vessel occlusion symptoms",
          "target": "No mismatch suggesting salvageable tissue",
          "contraindications": "Contrast issues",
          "ED": "EXT",
          "HOSP": "EXT",
          "OPD": "-",
          "ICU": "-"
        },
        {
          "item": "Vessel wall MRI",
          "timing": "Suspected intracranial vasculitis or dissection",
          "target": "No vessel wall enhancement",
          "contraindications": "MRI contraindications",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-"
        },
        {
          "item": "DSA (cerebral angiogram)",
          "timing": "Vasculitis workup, moyamoya, uncertain vessel status",
          "target": "Define vascular anatomy",
          "contraindications": "Contrast allergy, bleeding risk",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-"
        },
        {
          "item": "Implantable loop recorder",
          "timing": "Recurrent cryptogenic events after negative workup",
          "target": "Detect occult AF",
          "contraindications": "None",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-"
        }
      ]
    },
    "Treatment": {
      "Acute/Emergent": [
        {
          "item": "Aspirin",
          "route": "PO",
          "indication": "Immediate antiplatelet therapy",
          "dosing": {
            "doseOptions": [
              {
                "text": "325 mg PO x1 load",
                "orderSentence": "Aspirin 325 mg PO x1 load PO"
              },
              {
                "text": "81 mg PO daily",
                "orderSentence": "Aspirin 81 mg PO daily PO"
              }
            ],
            "route": "PO",
            "instructions": "325 mg loading dose, then 81 mg daily ongoing",
            "orderSentence": "Aspirin 325 mg PO x1 load PO"
          },
          "contraindications": "Active GI bleed; aspirin allergy; planned thrombolysis",
          "monitoring": "GI symptoms, bleeding",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Clopidogrel (DAPT with aspirin)",
          "route": "PO",
          "indication": "ABCD2 ≥4 or minor stroke; first 21 days",
          "dosing": {
            "doseOptions": [
              {
                "text": "300 mg PO x1 load",
                "orderSentence": "Clopidogrel (DAPT with aspirin) 300 mg PO x1 load PO"
              },
              {
                "text": "75 mg PO daily",
                "orderSentence": "Clopidogrel (DAPT with aspirin) 75 mg PO daily PO"
              }
            ],
            "route": "PO",
            "instructions": "300 mg load then 75 mg daily with aspirin x21 days (POINT/CHANCE protocol)",
            "orderSentence": "Clopidogrel (DAPT with aspirin) 300 mg PO x1 load PO"
          },
          "contraindications": "Active bleeding; planned surgery within 7 days",
          "monitoring": "Bleeding, bruising",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Ticagrelor (alternative DAPT)",
          "route": "PO",
          "indication": "Aspirin + ticagrelor if clopidogrel contraindicated",
          "dosing": {
            "doseOptions": [
              {
                "text": "180 mg PO x1 load",
                "orderSentence": "Ticagrelor (alternative DAPT) 180 mg PO x1 load PO"
              },
              {
                "text": "90 mg PO BID",
                "orderSentence": "Ticagrelor (alternative DAPT) 90 mg PO BID PO"
              }
            ],
            "route": "PO",
            "instructions": "180 mg load then 90 mg BID with aspirin x30 days (THALES protocol)",
            "orderSentence": "Ticagrelor (alternative DAPT) 180 mg PO x1 load PO"
          },
          "contraindications": "Active bleeding; prior ICH; severe hepatic impairment",
          "monitoring": "Bleeding, dyspnea",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Atorvastatin",
          "route": "PO",
          "indication": "High-intensity statin for LDL <70",
          "dosing": {
            "doseOptions": [
              {
                "text": "80 mg PO daily",
                "orderSentence": "Atorvastatin 80 mg PO daily PO"
              }
            ],
            "route": "PO",
            "instructions": "80 mg daily (high-intensity); target LDL <70 mg/dL",
            "orderSentence": "Atorvastatin 80 mg PO daily PO"
          },
          "contraindications": "Active liver disease; pregnancy",
          "monitoring": "LFTs at baseline; myalgias",
          "ED": "URGENT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Blood pressure management",
          "route": "-",
          "indication": "Permissive hypertension acutely; goal <140/90 long-term",
          "dosing": {
            "doseOptions": [
              {
                "text": "Target <180/110 first 24h",
                "orderSentence": "Blood pressure management Target <180/110 first 24h -"
              },
              {
                "text": "<140/90 after",
                "orderSentence": "Blood pressure management <140/90 after -"
              }
            ],
            "route": "-",
            "instructions": "Do NOT lower BP aggressively in first 24h unless >220/120 or end-organ damage",
            "orderSentence": "Blood pressure management Target <180/110 first 24h -"
          },
          "contraindications": "Symptomatic hypotension",
          "monitoring": "BP q1h x24h, then q4h",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Symptomatic Treatments": [
        {
          "item": "IV fluids (isotonic saline)",
          "route": "IV",
          "indication": "Maintain euvolemia; avoid hypotension",
          "dosing": {
            "doseOptions": [
              {
                "text": "75-125 mL/hr NS",
                "orderSentence": "IV fluids (isotonic saline) 75-125 mL/hr NS IV"
              }
            ],
            "route": "IV",
            "instructions": "75-125 mL/hr; adjust to maintain euvolemia; avoid D5W",
            "orderSentence": "IV fluids (isotonic saline) 75-125 mL/hr NS IV"
          },
          "contraindications": "Fluid overload, CHF",
          "monitoring": "Fluid balance, I/Os",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "ICU": "-"
        },
        {
          "item": "Pantoprazole",
          "route": "IV/PO",
          "indication": "GI protection with DAPT",
          "dosing": {
            "doseOptions": [
              {
                "text": "40 mg IV daily",
                "orderSentence": "Pantoprazole 40 mg IV daily IV/PO"
              },
              {
                "text": "40 mg PO daily",
                "orderSentence": "Pantoprazole 40 mg PO daily IV/PO"
              }
            ],
            "route": "IV/PO",
            "instructions": "40 mg daily",
            "orderSentence": "Pantoprazole 40 mg IV daily IV/PO"
          },
          "contraindications": "None",
          "monitoring": "None",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Second-line/Refractory": [
        {
          "item": "Cilostazol (triple antiplatelet)",
          "route": "PO",
          "indication": "Asian populations; high-risk stenosis",
          "dosing": {
            "doseOptions": [
              {
                "text": "100 mg PO BID",
                "orderSentence": "Cilostazol (triple antiplatelet) 100 mg PO BID PO"
              }
            ],
            "route": "PO",
            "instructions": "100 mg BID; add to aspirin in select cases",
            "orderSentence": "Cilostazol (triple antiplatelet) 100 mg PO BID PO"
          },
          "contraindications": "Heart failure; bleeding",
          "monitoring": "Bleeding, headache, palpitations",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-"
        },
        {
          "item": "Prasugrel",
          "route": "PO",
          "indication": "Clopidogrel resistance or failure",
          "dosing": {
            "doseOptions": [
              {
                "text": "60 mg PO x1 load",
                "orderSentence": "Prasugrel 60 mg PO x1 load PO"
              },
              {
                "text": "10 mg PO daily",
                "orderSentence": "Prasugrel 10 mg PO daily PO"
              }
            ],
            "route": "PO",
            "instructions": "60 mg load then 10 mg daily; avoid if >75y or <60 kg",
            "orderSentence": "Prasugrel 60 mg PO x1 load PO"
          },
          "contraindications": "Prior TIA/stroke (black box); bleeding risk",
          "monitoring": "Bleeding",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-"
        }
      ],
      "Disease-Modifying or Chronic Therapies (Secondary Prevention)": [
        {
          "item": "Aspirin (long-term)",
          "route": "PO",
          "indication": "Lifelong secondary prevention",
          "dosing": {
            "doseOptions": [
              {
                "text": "81 mg PO daily",
                "orderSentence": "Aspirin (long-term) 81 mg PO daily PO"
              }
            ],
            "route": "PO",
            "instructions": "81 mg daily indefinitely",
            "orderSentence": "Aspirin (long-term) 81 mg PO daily PO"
          },
          "pretreatment": "None",
          "contraindications": "Active GI bleed",
          "monitoring": "GI symptoms; annual CBC",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Clopidogrel (monotherapy)",
          "route": "PO",
          "indication": "Alternative to aspirin if aspirin-intolerant",
          "dosing": {
            "doseOptions": [
              {
                "text": "75 mg PO daily",
                "orderSentence": "Clopidogrel (monotherapy) 75 mg PO daily PO"
              }
            ],
            "route": "PO",
            "instructions": "75 mg daily",
            "orderSentence": "Clopidogrel (monotherapy) 75 mg PO daily PO"
          },
          "pretreatment": "None",
          "contraindications": "Active bleeding",
          "monitoring": "Bleeding",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Aspirin + extended-release dipyridamole (Aggrenox)",
          "route": "PO",
          "indication": "Alternative antiplatelet regimen",
          "dosing": {
            "doseOptions": [
              {
                "text": "25/200 mg PO BID",
                "orderSentence": "Aspirin + extended-release dipyridamole (Aggrenox) 25/200 mg PO BID PO"
              }
            ],
            "route": "PO",
            "instructions": "One capsule (25 mg ASA/200 mg ER dipyridamole) BID",
            "orderSentence": "Aspirin + extended-release dipyridamole (Aggrenox) 25/200 mg PO BID PO"
          },
          "pretreatment": "None",
          "contraindications": "Coronary stenosis (coronary steal); severe headache",
          "monitoring": "Headache (often limits use); GI",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Apixaban",
          "route": "PO",
          "indication": "Atrial fibrillation-related TIA",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 mg PO BID",
                "orderSentence": "Apixaban 5 mg PO BID PO"
              },
              {
                "text": "2.5 mg PO BID",
                "orderSentence": "Apixaban 2.5 mg PO BID PO"
              }
            ],
            "route": "PO",
            "instructions": "5 mg BID (2.5 mg BID if ≥2 of: age ≥80, weight ≤60 kg, Cr ≥1.5)",
            "orderSentence": "Apixaban 5 mg PO BID PO"
          },
          "pretreatment": "Active major bleeding; mechanical valve",
          "contraindications": "CrCl, bleeding signs",
          "monitoring": "-",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "-"
        },
        {
          "item": "Rivaroxaban",
          "route": "PO",
          "indication": "AF-related TIA",
          "dosing": {
            "doseOptions": [
              {
                "text": "20 mg PO daily",
                "orderSentence": "Rivaroxaban 20 mg PO daily PO"
              },
              {
                "text": "15 mg PO daily",
                "orderSentence": "Rivaroxaban 15 mg PO daily PO"
              }
            ],
            "route": "PO",
            "instructions": "20 mg daily with food (15 mg if CrCl 15-50)",
            "orderSentence": "Rivaroxaban 20 mg PO daily PO"
          },
          "pretreatment": "Active major bleeding; mechanical valve",
          "contraindications": "CrCl, bleeding",
          "monitoring": "-",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "-"
        },
        {
          "item": "Dabigatran",
          "route": "PO",
          "indication": "AF-related TIA",
          "dosing": {
            "doseOptions": [
              {
                "text": "150 mg PO BID",
                "orderSentence": "Dabigatran 150 mg PO BID PO"
              },
              {
                "text": "110 mg PO BID",
                "orderSentence": "Dabigatran 110 mg PO BID PO"
              }
            ],
            "route": "PO",
            "instructions": "150 mg BID (110 mg BID if CrCl 30-50 or age >80)",
            "orderSentence": "Dabigatran 150 mg PO BID PO"
          },
          "pretreatment": "Active bleeding; CrCl <30; mechanical valve",
          "contraindications": "CrCl, bleeding",
          "monitoring": "-",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "-"
        },
        {
          "item": "Warfarin",
          "route": "PO",
          "indication": "Mechanical valve; some hypercoagulable states",
          "dosing": {
            "doseOptions": [
              {
                "text": "2-10 mg PO daily adjusted",
                "orderSentence": "Warfarin 2-10 mg PO daily adjusted PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 5 mg daily; adjust to INR 2-3 (2.5-3.5 for mechanical valve)",
            "orderSentence": "Warfarin 2-10 mg PO daily adjusted PO"
          },
          "pretreatment": "Baseline INR",
          "contraindications": "Pregnancy; active bleeding; frequent falls",
          "monitoring": "INR weekly then monthly",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Lisinopril",
          "route": "PO",
          "indication": "Blood pressure control for secondary prevention",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 mg PO daily",
                "orderSentence": "Lisinopril 5 mg PO daily PO"
              },
              {
                "text": "10 mg PO daily",
                "orderSentence": "Lisinopril 10 mg PO daily PO"
              },
              {
                "text": "20 mg PO daily",
                "orderSentence": "Lisinopril 20 mg PO daily PO"
              },
              {
                "text": "40 mg PO daily",
                "orderSentence": "Lisinopril 40 mg PO daily PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 5-10 mg daily; titrate to goal BP <130/80; max 40 mg",
            "orderSentence": "Lisinopril 5 mg PO daily PO"
          },
          "pretreatment": "None",
          "contraindications": "Angioedema; pregnancy; bilateral RAS; hyperkalemia",
          "monitoring": "K+, Cr, BP",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Amlodipine",
          "route": "PO",
          "indication": "BP control; add-on therapy",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 mg PO daily",
                "orderSentence": "Amlodipine 5 mg PO daily PO"
              },
              {
                "text": "10 mg PO daily",
                "orderSentence": "Amlodipine 10 mg PO daily PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 5 mg daily; may increase to 10 mg daily",
            "orderSentence": "Amlodipine 5 mg PO daily PO"
          },
          "pretreatment": "None",
          "contraindications": "Severe aortic stenosis (relative)",
          "monitoring": "Peripheral edema, BP",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Chlorthalidone",
          "route": "PO",
          "indication": "BP control; thiazide-like diuretic",
          "dosing": {
            "doseOptions": [
              {
                "text": "12.5 mg PO daily",
                "orderSentence": "Chlorthalidone 12.5 mg PO daily PO"
              },
              {
                "text": "25 mg PO daily",
                "orderSentence": "Chlorthalidone 25 mg PO daily PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 12.5 mg daily; may increase to 25 mg daily",
            "orderSentence": "Chlorthalidone 12.5 mg PO daily PO"
          },
          "pretreatment": "None",
          "contraindications": "Severe hypokalemia; severe hyponatremia",
          "monitoring": "K+, Na+, uric acid, glucose",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Ezetimibe",
          "route": "PO",
          "indication": "Add-on for LDL not at goal on statin",
          "dosing": {
            "doseOptions": [
              {
                "text": "10 mg PO daily",
                "orderSentence": "Ezetimibe 10 mg PO daily PO"
              }
            ],
            "route": "PO",
            "instructions": "10 mg daily",
            "orderSentence": "Ezetimibe 10 mg PO daily PO"
          },
          "pretreatment": "None",
          "contraindications": "Severe hepatic impairment",
          "monitoring": "LFTs",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "PCSK9 inhibitor (evolocumab, alirocumab)",
          "route": "SC",
          "indication": "LDL >70 despite maximal statin + ezetimibe",
          "dosing": {
            "doseOptions": [
              {
                "text": "140 mg SC q2wk",
                "orderSentence": "PCSK9 inhibitor (evolocumab, alirocumab) 140 mg SC q2wk SC"
              },
              {
                "text": "420 mg SC monthly",
                "orderSentence": "PCSK9 inhibitor (evolocumab, alirocumab) 420 mg SC monthly SC"
              }
            ],
            "route": "SC",
            "instructions": "Evolocumab 140 mg q2wk or 420 mg monthly; alirocumab 75-150 mg q2wk",
            "orderSentence": "PCSK9 inhibitor (evolocumab, alirocumab) 140 mg SC q2wk SC"
          },
          "pretreatment": "LFTs, lipid panel",
          "contraindications": "None",
          "monitoring": "Injection site reactions; LDL",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Icosapent ethyl (Vascepa)",
          "route": "PO",
          "indication": "Triglycerides ≥150 despite statin; reduces CV events",
          "dosing": {
            "doseOptions": [
              {
                "text": "2 g PO BID",
                "orderSentence": "Icosapent ethyl (Vascepa) 2 g PO BID PO"
              }
            ],
            "route": "PO",
            "instructions": "2 g BID with meals",
            "orderSentence": "Icosapent ethyl (Vascepa) 2 g PO BID PO"
          },
          "pretreatment": "None",
          "contraindications": "Seafood/fish allergy (relative)",
          "monitoring": "AF monitoring (slightly increased risk)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Carotid endarterectomy (CEA)",
          "route": "Surgical",
          "indication": "Symptomatic carotid stenosis 70-99%; 50-69% in select",
          "dosing": {
            "doseOptions": [
              {
                "text": "Surgery",
                "orderSentence": "Carotid endarterectomy (CEA) Surgery Surgical"
              }
            ],
            "route": "Surgical",
            "instructions": "Perform within 2 weeks of TIA if stable; high-volume surgeon",
            "orderSentence": "Carotid endarterectomy (CEA) Surgery Surgical"
          },
          "pretreatment": "None",
          "contraindications": "Unstable plaque with delay; total occlusion",
          "monitoring": "Surgical complications; stroke",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "-",
          "ICU": "-"
        },
        {
          "item": "Carotid artery stenting (CAS)",
          "route": "Endovascular",
          "indication": "CEA high-risk; radiation neck; recurrent stenosis",
          "dosing": {
            "doseOptions": [
              {
                "text": "Stenting",
                "orderSentence": "Carotid artery stenting (CAS) Stenting Endovascular"
              }
            ],
            "route": "Endovascular",
            "instructions": "Alternative to CEA; requires DAPT",
            "orderSentence": "Carotid artery stenting (CAS) Stenting Endovascular"
          },
          "pretreatment": "None",
          "contraindications": "Tortuous anatomy; heavy calcification",
          "monitoring": "Hyperperfusion syndrome; stroke",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "-",
          "ICU": "-"
        },
        {
          "item": "PFO closure",
          "route": "Endovascular",
          "indication": "Age <60, PFO with shunt, cryptogenic stroke/TIA",
          "dosing": {
            "doseOptions": [
              {
                "text": "Device closure",
                "orderSentence": "PFO closure Device closure Endovascular"
              }
            ],
            "route": "Endovascular",
            "instructions": "Consider after comprehensive evaluation; DAPT post-procedure",
            "orderSentence": "PFO closure Device closure Endovascular"
          },
          "pretreatment": "None",
          "contraindications": "Small PFO without shunt",
          "monitoring": "AF (transient); device complications",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-"
        }
      ]
    },
    "Other Recommendations": {
      "Referrals & Consults": [
        {
          "item": "Neurology/Stroke consult for urgent evaluation, risk stratification, and secondary prevention optimization",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Cardiology consultation for atrial fibrillation management, anticoagulation decisions, and PFO evaluation",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Vascular surgery consultation for symptomatic carotid stenosis ≥50% to evaluate for endarterectomy timing",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Interventional neurology for carotid stenting evaluation if CEA high-risk or anatomically unsuitable",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Cardiac electrophysiology for recurrent AF management and potential ablation",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Registered dietitian for Mediterranean diet counseling and sodium restriction education",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Smoking cessation counseling and pharmacotherapy initiation if current smoker",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Patient Instructions": [
        {
          "item": "Call 911 immediately if symptoms return as this indicates high stroke risk (up to 10% in first 48 hours)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE"
        },
        {
          "item": "Do not drive for at least 2-4 weeks after TIA per state regulations and stroke risk",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Take all medications as prescribed especially antiplatelet therapy which significantly reduces stroke risk",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Know stroke warning signs (FAST: Face drooping, Arm weakness, Speech difficulty, Time to call 911)",
          "ED": "STAT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Keep follow-up appointments as early intervention reduces stroke risk by up to 80%",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        }
      ],
      "Lifestyle & Prevention": [
        {
          "item": "Blood pressure target <130/80 mmHg to significantly reduce stroke recurrence risk",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "LDL target <70 mg/dL with high-intensity statin for secondary prevention",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Smoking cessation (reduces stroke risk by 50% within 1 year of quitting)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Mediterranean diet emphasizing fruits, vegetables, whole grains, fish, and olive oil",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Limit alcohol to ≤1 drink/day for women, ≤2 drinks/day for men",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Regular aerobic exercise (150 min/week moderate or 75 min/week vigorous)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Weight management with target BMI 18.5-24.9 kg/m²",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Sodium restriction <2300 mg/day (ideally <1500 mg if hypertensive)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        }
      ]
    }
  },
  "differential": [
    {
      "diagnosis": "Migraine with aura",
      "features": "Gradual onset (minutes), visual scintillations, headache follows; younger patient",
      "tests": "Clinical history; normal DWI"
    },
    {
      "diagnosis": "Seizure with Todd's paralysis",
      "features": "Preceding convulsion; confusion; gradual resolution over hours",
      "tests": "EEG; clinical history"
    },
    {
      "diagnosis": "Hypoglycemia",
      "features": "Altered mentation, diaphoresis, tremor; resolves with glucose",
      "tests": "Fingerstick glucose"
    },
    {
      "diagnosis": "Peripheral vertigo (BPPV, vestibular neuritis)",
      "features": "Isolated vertigo with nystagmus; positive Dix-Hallpike",
      "tests": "HINTS exam; no central signs"
    },
    {
      "diagnosis": "Transient global amnesia",
      "features": "Isolated anterograde amnesia; repetitive questioning; resolves <24h",
      "tests": "Clinical criteria; DWI may show hippocampal lesions"
    },
    {
      "diagnosis": "Functional neurological disorder",
      "features": "Inconsistent exam; incongruent symptoms; often with psychiatric comorbidity",
      "tests": "Clinical exam; normal workup"
    },
    {
      "diagnosis": "Bell's palsy",
      "features": "Peripheral facial weakness (forehead involved); no other deficits",
      "tests": "Clinical exam"
    },
    {
      "diagnosis": "Hypertensive encephalopathy",
      "features": "Severe HTN; headache; confusion; visual changes",
      "tests": "BP, posterior MRI findings"
    },
    {
      "diagnosis": "Demyelinating disease (MS)",
      "features": "Younger patient; prior episodes; MRI with characteristic lesions",
      "tests": "MRI brain/spine; CSF"
    }
  ],
  "evidence": [
    {
      "recommendation": "Dual antiplatelet therapy (DAPT) for 21 days after minor stroke/TIA",
      "evidenceLevel": "Class I, Level A",
      "source": "[Wang et al. NEJM 2021 (CHANCE-2)](https://pubmed.ncbi.nlm.nih.gov/34265411/); [Johnston et al. NEJM 2018 (POINT)](https://pubmed.ncbi.nlm.nih.gov/29766749/)"
    },
    {
      "recommendation": "High-intensity statin for LDL <70 mg/dL",
      "evidenceLevel": "Class I, Level A",
      "source": "[Amarenco et al. NEJM 2006 (SPARCL)](https://pubmed.ncbi.nlm.nih.gov/16899775/)"
    },
    {
      "recommendation": "CEA for symptomatic carotid stenosis 70-99%",
      "evidenceLevel": "Class I, Level A",
      "source": "[NASCET Collaborators. NEJM 1991](https://pubmed.ncbi.nlm.nih.gov/1852179/)"
    },
    {
      "recommendation": "ABCD2 score for TIA risk stratification",
      "evidenceLevel": "Class IIa, Level B",
      "source": "[Johnston et al. Lancet 2007](https://pubmed.ncbi.nlm.nih.gov/17258668/)"
    },
    {
      "recommendation": "Extended cardiac monitoring for cryptogenic stroke",
      "evidenceLevel": "Class IIa, Level B",
      "source": "[Sanna et al. NEJM 2014 (CRYSTAL-AF)](https://pubmed.ncbi.nlm.nih.gov/24963567/)"
    },
    {
      "recommendation": "PFO closure in cryptogenic stroke <60 years",
      "evidenceLevel": "Class IIa, Level B",
      "source": "[Mas et al. NEJM 2017 (CLOSE)](https://pubmed.ncbi.nlm.nih.gov/28902593/)"
    },
    {
      "recommendation": "BP target <130/80 for secondary prevention",
      "evidenceLevel": "Class I, Level B",
      "source": "[AHA/ASA Guidelines 2021](https://pubmed.ncbi.nlm.nih.gov/34024117/)"
    },
    {
      "recommendation": "Urgent TIA evaluation reduces stroke risk",
      "evidenceLevel": "Class I, Level B",
      "source": "[Rothwell et al. Lancet 2007 (EXPRESS)](https://pubmed.ncbi.nlm.nih.gov/17928046/)"
    },
    {
      "recommendation": "DOACs preferred over warfarin for NVAF",
      "evidenceLevel": "Class I, Level A",
      "source": "[Ruff et al. Lancet 2014 (meta-analysis)](https://pubmed.ncbi.nlm.nih.gov/24315724/)"
    }
  ],
  "monitoring": [
    {
      "item": "Neurological exam",
      "frequency": "q1h x 24h then q4h",
      "action": "Immediate imaging if worsening",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "-",
      "ICU": "-"
    },
    {
      "item": "Blood pressure",
      "frequency": "q1h x 24h then q4h",
      "action": "Titrate antihypertensives",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Cardiac rhythm (telemetry)",
      "frequency": "Continuous x 24-72h",
      "action": "Anticoagulation if AF detected",
      "ED": "URGENT",
      "HOSP": "STAT",
      "OPD": "-",
      "ICU": "-"
    },
    {
      "item": "Extended cardiac monitoring",
      "frequency": "14-30 days outpatient",
      "action": "Anticoagulation if AF detected",
      "ED": "-",
      "HOSP": "-",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "ABCD2 score",
      "frequency": "At presentation",
      "action": "High-risk patients need admission or rapid TIA clinic",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "-",
      "ICU": "-"
    },
    {
      "item": "LDL cholesterol",
      "frequency": "Baseline, 6 weeks, then annually",
      "action": "Intensify statin or add ezetimibe/PCSK9i",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "HbA1c",
      "frequency": "Baseline, then q3mo if diabetic",
      "action": "Optimize diabetes management",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    },
    {
      "item": "Creatinine/eGFR",
      "frequency": "With contrast; then annually",
      "action": "Dose-adjust medications",
      "ED": "STAT",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-"
    }
  ],
  "disposition": [
    {
      "disposition": "Rapid TIA clinic (<24-48h)",
      "criteria": "ABCD2 <4; no acute findings on imaging; reliable patient with close follow-up"
    },
    {
      "disposition": "Admit to stroke unit",
      "criteria": "ABCD2 ≥4; DWI positive (minor stroke); symptomatic carotid stenosis; new AF; unable to complete workup as outpatient"
    },
    {
      "disposition": "Admit to ICU",
      "criteria": "Rare for isolated TIA; only if concurrent acute coronary syndrome or hemodynamic instability"
    },
    {
      "disposition": "Discharge with urgent follow-up",
      "criteria": "Completed rapid workup; started on secondary prevention; ABCD2 <4; no high-risk features"
    }
  ]
}